Cellectar Biosciences, Inc. (CLRB) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-8.35 | +80.1% |
| 2024 | $-41.89 | -1096.9% |
| 2023 | $-3.50 | +22.4% |
| 2022 | $-4.51 | -3.7% |
| 2021 | $-4.35 | -136.4% |
| 2020 | $-1.84 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-8.35 | +80.1% |
| 2024 | $-41.89 | -1096.9% |
| 2023 | $-3.50 | +22.4% |
| 2022 | $-4.51 | -3.7% |
| 2021 | $-4.35 | -136.4% |
| 2020 | $-1.84 | — |